Results 191 to 200 of about 31,119,208 (308)

Type 2 diabetes mellitus complicated by acquired reactive perforating collagenosis: A case report and literature review. [PDF]

Medicine (Baltimore)
Li L, Wu H, Zhao L.
europepmc   +1 more source

Impact of the pancreatic enzyme replacement therapy (PERT) shortage on prescribing in England: Analysis of national data

British Journal of Clinical Pharmacology, EarlyView.
Aim Pancreatic enzyme replacement therapy (PERT) is essential for the management of pancreatic exocrine insufficiency. Since June 2023, the United Kingdom has been affected by a global shortage of PERT. We investigated the impact of this shortage on national prescribing trends for Creon, Nutrizym, Pancrex and Pangrol.
Teena S. Varghese, Mary E. Phillips, Louis Fisher, Helen Fitt, Adam Frampton, Christopher Wood, Agnieszka Lemanska   +6 more
wiley   +1 more source

Basal Metabolic Rate, Genetic Susceptibility, and Type 2 Diabetes Mellitus Events in Adults. [PDF]

Diabetes Metab J
Yuan L, Si K, Peng H, Sun J, Zhao Z.
europepmc   +1 more source

Clozapine:norclozapine ratio as a marker of metabolic risk and therapeutic response and effect of valproate on clozapine levels

British Journal of Clinical Pharmacology, EarlyView.
Aims Clozapine is the most effective antipsychotic in treatment‐resistant schizophrenia. Clozapine causes weight gain and increased diabetes risk. The role of its metabolite norclozapine and clozapine:norclozapine ratio (CLZ/NCLZ) in metabolic effects has been debated.
Susanna Maria Rask, Miina Lamminmäki, Olli Kampman, Mari Hämäläinen, Eeva Moilanen, Niko Seppälä, Anssi Solismaa   +6 more
wiley   +1 more source

Exercise-induced metabolic remodeling in type 2 diabetes mellitus: insights from metabolomics. [PDF]

Front Endocrinol (Lausanne)
Xiang H, Miao J, Cheng J, Yuan J, Gong H, Han Y, Gao L.   +6 more
europepmc   +1 more source

Pharmacogenomics of dolutegravir: A scoping review of evidence, gaps and clinical implications

British Journal of Clinical Pharmacology, EarlyView.
Dolutegravir underpins modern first‐ and second‐line HIV treatment regimens; however, interindividual variability in its disposition and tolerability presents challenges for optimal use. This scoping review mapped current evidence on the pharmacogenomics of dolutegravir, focusing on pharmacokinetics and pharmacodynamics, and methodological limitations ...
Ronald Kiguba, Mishael Ssesanga, Munir Pirmohamed   +2 more
wiley   +1 more source

Association Between Iron Metabolism and Microalbuminuria in Patients With Type 2 Diabetes Mellitus and MASLD. [PDF]

Int J Endocrinol
Qu H, Zhou L, Hu J, Tang D, Yang L.
europepmc   +1 more source

Safety outcomes of antidiabetic medications: A comprehensive review of the EU summaries of product characteristics and international clinical practice guidelines

British Journal of Clinical Pharmacology, EarlyView.
Aims Information on the safety profile of antidiabetic medications is essential for informed treatment decisions in type 2 diabetes mellitus. Although this information is available in regulatory documents of individual drugs, a comprehensive overview across all approved antidiabetics is lacking.
David Liang, Daniala L. Weir, Safana Thevasahayam, Vera H. M. Deneer, Arno Siebes, Helga Gardarsdottir   +5 more
wiley   +1 more source

Mehamudgaravati and type 2 diabetes mellitus

AYU (An international quarterly journal of research in Ayurveda), 2011
openaire   +3 more sources

Association of HDL2b with chronic kidney disease in type 2 diabetes mellitus populations. [PDF]

Front Endocrinol (Lausanne)
Tang H, Ye Z, Hong G, Li X, Liang Y, Zou H, Deng D.   +6 more
europepmc   +1 more source